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Abstract
Background: Parkinson's disease is the second most common neurodegenerative disorder after
Alzheimer's disease. Most cases are sporadic, however familial cases do exist. We examined 12
families with familial Parkinson's disease ascertained at the Movement Disorder clinic at the Oregon
Health Sciences University for genetic linkage to a number of candidate loci. These loci have been
implicated in familial Parkinson's disease or in syndromes with a clinical presentation that overlaps
with parkinsonism, as well as potentially in the pathogenesis of the disease.
Methods: The examined loci were PARK3, Parkin, DRD (dopa-responsive dystonia), FET1 (familial
essential tremor), BDNF  (brain-derived neurotrophic factor), GDNF  (glial cell line-derived
neurotrophic factor), Ret, DAT1 (the dopamine transporter), Nurr1 and Synphilin-1. Linkage to the
α-synuclein gene and the Frontotemporal dementia with parkinsonism locus on chromosome 17 had
previously been excluded in the families included in this study. Using Fastlink, Genehunter and
Simwalk both parametric and model-free non-parametric linkage analyses were performed.
Results: In the multipoint parametric linkage analysis lod scores were below -2 for all loci except
FET1 and Synphilin-1 under an autosomal dominant model with incomplete penetrance. Using non-
parametric linkage analysis there was no evidence for linkage, although linkage could not be
excluded. A few families showed positive parametric and non-parametric lod scores indicating
possible genetic heterogeneity between families, although these scores did not reach any degree of
statistical significance.
Conclusions: We conclude that in these families there was no evidence for linkage to any of the
loci tested, although we were unable to exclude linkage with both parametric and non-parametric
methods.
Background
Parkinson's disease (PD) is considered to be a multifacto-
rial disease. Seventy to ninety percent of cases are esti-
mated to be sporadic, while ten to thirty percent are
familial [1]. Several rare PD families have been reported
displaying different modes of inheritance. In the majority
of families there is no clear inheritance pattern; however,
in some cases is the disease clearly inherited in an auto-
somal dominant or an autosomal recessive mode. Clini-
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cally and neuropathologically, familial and sporadic PD
seem to be similar [1], although in some familial cases
atypical features accompany parkinsonism. In frontotem-
poral dementia linked to chromosome 17 (FTDP-17),
patients display frontal lobe dementia and mutations
have been identified in the Tau gene on chromosome 17
[2]. Dystonia is a prominent feature in dopa-responsive
dystonia, a disease in which mutations have been found
in the GTP cyclohydrolase 1 gene on chromosome 4 [3].
To date, ten genes have been implicated in PD. The first
PD mutation was found in the α-synuclein gene on chro-
mosome 4 in a large Greek-American kindred with auto-
somal dominant inheritance [4]. Clinical and
neuropathological features were similar to sporadic PD,
although with relatively early disease onset and rapid
course. In 1998, mutations in the Parkin  gene were
reported to be segregating with juvenile autosomal reces-
sive parkinsonism [5]. Subsequently, a large number of
Parkin  mutations were reported both in familial early-
onset PD and sporadic early-onset cases [6]. A mutation
was also found in the Ubiquitin carboxy-terminal hydrolase
L1 (UCH-L1) gene in one German sib pair with PD [7].
Recently, mutations in the DJ-1 gene were associated with
autosomal recessive parkinsonism in two European fami-
lies [8]. In addition to the genes described above, studies
have linked six previously uncharacterized loci to PD. The
PARK3 locus on chromosome 2 was linked to the disease
in several autosomal dominant PD families and the pene-
trance of the putative gene was estimated at about forty
percent [9]. In 1999, a chromosome 4p haplotype was
reported to be segregating with the disease in a large ped-
igree with autosomal dominant PD [10]. In this pedigree
individuals who did not have PD but postural tremor also
shared the haplotype, suggesting a common mutation for
the two phenotypes. In a large Sicilian family with auto-
somal recessive early-onset parkinsonism a locus on chro-
mosome 1p (PARK6) was reported to be linked to the
disease [11]. Hicks and coworkers reported linkage of
another locus on chromosome 1p (PARK10) to late-onset
PD in 51 Icelandic families [12]. Further, the PARK8 locus
on chromosome 12 was linked to PD in a Japanese family
with autosomal dominant parkinsonism [13]; and
recently, a PD susceptibility locus on chromosome 2 was
reported in 150 PD families [14].
In analyzing 12 Caucasian PD families ascertained in the
northwestern US, we previously excluded linkage to chro-
mosome 4q (α-synuclein) and the G209A mutation found
in the Greek-American kindred [15]. Dominant muta-
tions within the FTDP-17 locus were also excluded. Using
parametric linkage analysis we found suggestive linkage to
the PARK3 locus in a subset of families, although the locus
was excluded in at least one family [16]. In this study we
examined this locus further using non-parametric linkage
analysis. We also analyzed genes or loci that are related to
syndromes with parkinsonism such as juvenile parkinson-
ism (Parkin), dopa-responsive dystonia (DRD) and famil-
ial essential tremor (FET1), as well as genes or loci that are
biologically implicated in survival or function of
dopaminergic neurons, indicating potential involvement
in PD pathogenesis. These included the following: BDNF
(brain-derived neurotrophic factor), GDNF (glial cell line-
derived neurotrophic factor), Ret, DAT1 (the dopamine
transporter),  Nurr1  and Synphilin-1. The candidate loci
that were tested are described in Table 1. BDNF and GDNF
are both neurotrophic factors for dopaminergic neurons
[17,18] and they also protect nigral dopamine neurons in
animal models of PD [19,20]. Ret is the receptor of GDNF
[21]. The dopamine transporter is involved in the
reuptake of dopamine into dopaminergic neurons [22].
Nurr1 is a steroid receptor, and a knockout of its mouse
Table 1: Description, chromosomal location and microsatellite markers for the candidate loci that were investigated.
Locus Description Chromosome Map Reference
PARK3 Parkinson's disease 
susceptibility
2p13 D2S441-1.6cM-D2S2113-1.4cM-D2S291-0.5cM-
D2S2111-0.1cM-D2S2109-1.9cM-D2S1394
Gasser et al, 1998 [9]
Nurr1 Steroid receptor 2q22-23 D2S142-0.7cM-D2S284 Mages et al, 1994 [39]
FET1 Familial essential tremor 3q13 D3S1278-9.3cM-D3S1267 Gulcher et al, 1997 [30]
DAT1 Dopamine transporter 5p15 DAT1VNTR-5.5cM-D5S1455-8cM-D5S817 Vandenbergh et al, 1992 [40]
GDNF Glial cell line-derived 
neurotrophic factor
5p12-13 D5S674-4.8cM-D5S426-0.6cM-D5S395 Schindelhauer et al, 1995 [41]
Synphilin-1 Interacts with α-synuclein 5q23 D5S492-13.8cM-D5S657 Engelender et al, 1999 [25]
Parkin Juvenile recessive 
Parkinson's disease
6q25-27 D6S305-0.3cM-D6S411 Kitada et al, 1998 [5]
Ret Receptor of GDNF 10q11.2 D10S141 Ishizaka et al, 1989 [42]
BDNF Brain-derived neurotrophic 
factor
11p13 D11S1324-3.4cM-D11S914-0.3cM-D11S1322 Maisonpierre et al, 1991 [43]
DRD Dopa-responsive dystonia 14q22 D14S583-0.3cM-D14S587-0.3cM-D14S301 Ichinose et al, 1994 [3]BMC Neurology 2003, 3 http://www.biomedcentral.com/1471-2377/3/6
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homologue causes agenesis of dopaminergic neurons
[23]. Recently, two mutations in Nurr1 were found to be
segregating with PD in ten families of European descent
[24]. Synphilin-1 interacts with α-synuclein and is also
present in Lewy bodies, the neuropathological hallmark
of PD [25,26]. With both parametric and non-parametric
linkage analysis we found no evidence for linkage to any
of these loci. We included a non-parametric approach in
which no assumptions about mode of inheritance are
made, since the inheritance mode in the present material
is not completely ascertained.
Methods
Families
In total 12 families with familial PD, diagnosed at the
Movement Disorder clinic at Oregon Health Sciences Uni-
versity, were included in the study. The number of affected
and unaffected individuals in each family, age of onset
characteristics for affected and age characteristics for unaf-
fected are shown in Table 2. Diagnostic criteria according
to the UK Parkinson's Disease Society Brain Bank [27]
were used with the exception that family history of PD
was not used as an exclusion criterion. Individuals who
fulfilled these criteria were classified as probable PD. In
addition, individuals who did not fulfill the UK Parkin-
son's Disease Society Brain Bank criteria but showed at
least one cardinal sign (mostly tremor) were classified as
possible PD. The majority of families had a segregation
pattern that was consistent with an autosomal dominant
mode of inheritance. Examples of relationships between
affected individuals were son/daughter, sibling, aunt/
uncle, granddaughter/grandson, first cousin and second
cousin. In ten families, there were at least three individu-
als with probable PD. Referring to individuals with both
probable and possible PD, there were in total 107 affected
individuals. Of these, blood was collected from 53 indi-
viduals with the average of 4.4 individuals per family. The
largest number of sampled affected individuals in one
family was nine (family 5 in Table 2). Previously, the
G209A mutation in α-synuclein found in the large Greek-
American kindred was found to be absent in these fami-
lies and linkage to chromosome 4q21-23 where this gene
is situated was excluded [15]. A subset of the families was
also tested for the PARK3 locus on chromosome 2 [16].
All individuals included in the study signed an informed
consent form approved by the Institutional Review Board
at the Oregon Health Sciences University in compliance
with the Helsinki Declaration.
Statistical power calculation
The statistical power of the family material was assessed
by simulations using Simlink version 4.1 [28] under the
assumptions of autosomal dominant inheritance with
incomplete penetrance (55%) and no phenocopies, no
heterogeneity, a disease allele frequency of 0.001 and one
marker with four alleles. The simulations were performed
assigning individuals who were diagnosed with probable
PD as affected in addition to also allowing for those with
possible PD to be assigned as affected. We refer to proba-
ble PD as narrow definition PD. Probable PD and possi-
ble PD taken together is referred to as broad definition
PD. For narrow definition PD, the estimated mean maxi-
Table 2: Description of the PD family material. Number of affected and unaffected individuals in each family, mean age at onset and 
range for affected, and mean age and range for unaffected, as of 1997. In narrow definition PD only individuals with probable PD were 
assigned as affected. In broad definition PD both individuals with probable and possible PD were assigned as affected.
Narrow definition PD Broad definition PD Unaffected
Family N of 
individuals 
(total / 
sampled)
Mean age at 
onset
Range of age 
at onset
N of 
individuals 
(total / 
sampled)
Mean age at 
onset 
(sampled 
only)
Range of age 
at onset 
(sampled 
only)
N of 
unaffected 
individuals 
sampled
Mean age Age range
1 4 / 2 65.8 58–73 9 / 4 69.5 63–73 4 76.8 72–83
2 4 / 3 67.3 49–79 6 / 5 52.4 32–77 9 49.9 24–72
3 4 / 2 55.3 44–77 8 / 3 65.3 44–77 13 56.7 29–85
4 4 / 2 54.3 48–59 6 / 4 55.8 26–85 12 53.7 27–75
5 5 / 3 63.0 48–78 16 / 9 55.8 9–78 16 56.4 41–86
6 4 / 3 24.0 8–35 16 / 3 20.3 8–28 2 29.5 16–43
7 4 / 3 65.8 40–78 14 / 6 42.5 10–78 7 67.7 48–91
8 2 / 2 49.0 15–83 6 / 5 30.0 14–83 10 43.4 23–84
9 3 / 2 59.0 46–76 9 / 3 55.3 46–65 3 55.7 47–73
10 3 / 3 62.3 54–76 9 / 6 59.5 40–79 13 51.7 30–79
11 3 / 3 58.7 39–78 6 / 3 58.7 39–78 8 56.0 46–73
12 2 / 2 66.5 66–67 2 / 2 66.5 66–67 8 68.3 63–74BMC Neurology 2003, 3 http://www.biomedcentral.com/1471-2377/3/6
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mum lod score at theta = 0 summarized across all families
was 3.75 (standard error 0.046). The lowest mean maxi-
mum lod score in an individual family was 0.21 and the
highest 0.55. For broad definition PD, the estimated
mean maximum lod score at theta = 0 summarized across
all families was 7.48 (standard error 0.055), with the low-
est value in an individual family being 0.22 and the high-
est 1.17. Thus, the expected summarized maximum lod
scores would reach above 3.0, the commonly used level of
statistical significance, for both definitions of the pheno-
type. Considering both narrow and broad definition PD,
families 2, 5 and 11 gave the highest estimated mean max-
imum lod scores (0.55, 0.46 and 0.55 for narrow defini-
tion PD; 0.99, 1.17 and 0.93 for broad definition PD,
respectively) and families 1, 6 and 9 gave the lowest (0.21,
0.27 and 0.22 for narrow definition PD; 0.40, 0.22 and
0.35 for broad definition PD, respectively).
Genotyping
Highly polymorphic microsatellite markers were selected
for each locus using National Center for Biotechnology
Information databases [29]. Markers located in close
proximity to the locus or gene of interest were preferen-
tially selected. For those loci where gene information was
limited (PARK3, FET1), the markers that yielded the high-
est lod scores in previous publications were selected
[9,30]. The genetic localization and allele frequencies
were determined using publicly available databases [29].
The markers and the genetic maps used are listed in Table
1. The marker D10S141 for the Ret locus was an intragenic
marker [31] and the only marker selected for this locus.
The markers were PCR amplified using standard protocols
provided by Research Genetics. The PCR products were
separated on an ABI 377 Automatic Sequencer and the
genotypes were determined using Genescan™ and Geno-
Typer™ software (Perkin Elmer Applied Biosystems).
Linkage analysis
Two-point parametric linkage analysis was performed
with Fastlink version 4.1P [32]. Multipoint linkage analy-
sis was carried out with Genehunter version 2.0 beta [33],
which computes both parametric and non-parametric
multipoint lod scores. Due to the fact that Genehunter
cannot handle large pedigrees without subdividing them,
the non-parametric approach was complemented with
Simwalk version 2.60, which performs simulated anneal-
ing and random walk to compute a location score which
is comparable to multipoint lod score [34]. The assump-
tions for the parametric approach were an autosomal
dominant inheritance model with 55% penetrance, no
phenocopies, no heterogeneity and a disease allele fre-
quency of 0.001. Allele frequencies were estimated from
founders in the families and equal allele frequencies were
used for comparison. An affecteds-only and an autosomal
recessive model were also applied for the PARK3 and the
Parkin loci, respectively. All analyses were performed both
for narrow definition PD and broad definition PD.
Results
Analysis of narrow definition PD
Parametric linkage analysis
In additional file 1 (Table 3.xls), summarized parametric
two-point and multipoint lod scores and non-parametric
multipoint lod scores are presented for each marker exam-
ined for narrow and broad definition PD. For narrow def-
inition PD two-point lod scores were negative at theta = 0
for all markers examined. At theta = 0.1, two-point lod
scores were higher although still negative for all markers
except two, the highest value being 0.26 (for marker
D2S2113). Parametric multipoint lod scores were nega-
tive for all markers and below -2 (the commonly used
level for exclusion of linkage) for all markers and loci
except FET1, for which one of the two markers showed a
parametric lod score of -1.50. Equal allele frequencies and
allele frequencies estimated from the families yielded sim-
ilar results. For most of the markers information content
as given by Genehunter was above 60%. Information con-
tent was above 50% for all markers except DAT1VNTR,
D5S492 and D5S657.
In addition to the autosomal dominant model with
incomplete penetrance, an affecteds-only model and an
autosomal recessive model were applied for the PARK3
and Parkin loci respectively, since these loci were initially
identified using these models [5,9]. For five of the six
markers covering the PARK3 locus summarized paramet-
ric multipoint lod scores assuming an affecteds-only
model were between -2.98 and -2.87. One marker showed
a parametric multipoint lod score of -0.73. However,
information content decreased significantly from above
70% for the autosomal dominant model to between 20
and 40% for the affecteds-only model. For the Parkin
locus the autosomal recessive model showed higher para-
metric lod scores than the autosomal dominant model,
although still negative. For the two markers covering the
Parkin  locus summarized parametric multipoint lod
scores were -1.40 and -1.46 under the recessive model,
compared to -6.00 and -6.33 under the dominant model.
Non-parametric linkage analysis
For three loci (GDNF, BDNF and DRD) summarized non-
parametric multipoint lod scores were negative for all cov-
ering markers (additional file 1: Table 3.xls). For the other
loci non-parametric lod scores were slightly positive
although none reached above 1.0. The non-parametric
analysis was complemented by Simwalk, which computes
a statistic comparable to the non-parametric lod score.
The results generated by this approach were consistent
with the non-parametric results from Genehunter for all
loci except Parkin, BDNF and DRD. For these loci SimwalkBMC Neurology 2003, 3 http://www.biomedcentral.com/1471-2377/3/6
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computed higher values for the statistic corresponding to
the non-parametric lod score generated by Genehunter,
although all values were below 0.8 (data not shown).
Analysis of broad definition PD
When assigning individuals who were diagnosed with
possible PD (having one cardinal sign) as affected in addi-
tion to those with probable PD, lower summarized two-
point lod scores at theta = 0 were observed for all markers
except D2S2109, D2DS142, DAT1VNTR, D5S492 and
D6S411. Similarly, lower summarized parametric
multipoint lod scores were generated at all loci except
Nurr1, Synphilin-1 and Parkin (markers D2S142, D2S284,
D5S492 and D6S411) (additional file 1: Table 3.xls).
Slightly higher non-parametric multipoint lod scores were
observed for most of the markers, a result that agreed in
almost all cases with the Simwalk results. However, for all
loci in which non-parametric multipoint lod scores
obtained by Genehunter were above 1.0 (Nurr1, FET1,
Parkin and BDNF), the corresponding statistic generated
by Simwalk did not exceed 0.8 (data not shown). For
Nurr1,  FET1,  Synphilin-1,  Parkin  and  Ret, summarized
non-parametric multipoint lod scores were positive for all
markers both when narrow and broad definition PD were
applied. However, none achieved a level of significant
linkage.
Individual pedigree analysis
In additional file 2 (Table 4.xls), parametric and non-par-
ametric multipoint lod scores for narrow and broad defi-
nition PD are presented for each family and locus in
which both parametric and non-parametric lod scores
were positive and either of them exceeded the value of 0.5
for all markers. Most of the families and loci that fulfilled
these requirements for narrow definition PD also did so
for broad definition PD. These families were family 1 (for
the Nurr1 locus), family 3 (for the Nurr1 and Parkin loci),
family 6 (for the DRD  locus), family 7 (for the DAT1
locus), family 9 (for the PARK3 and FET1 loci) and family
11 (for the Ret and DRD loci). In the majority of these
cases both parametric and non-parametric lod scores were
higher for broad definition PD than for narrow definition
PD. The highest parametric lod score was observed when
broad definition PD was applied in family 11 at the Ret
locus (1.15; two-point lod score at theta = 0), correspond-
ing to a non-parametric lod score of 1.09. The highest
non-parametric multipoint lod score was obtained in
family 8 at the BDNF locus (2.57), also using broad defi-
nition PD, with a corresponding parametric multipoint
lod score of 1.05.
Discussion
In these 12 PD families there was no evidence for linkage
to any of the loci tested using parametric linkage analysis
under a model of autosomal dominant inheritance with
reduced penetrance, as well as non-parametric linkage
analysis. When performing parametric linkage analysis it
is important to specify both the disease-locus and marker-
locus parameters correctly. Generally, multipoint analysis
is more sensitive to various types of errors than two-point
analysis [35,36]. In two-point analysis misspecification of
inheritance mode may result in overestimation of recom-
bination fraction and reduced power to detect linkage,
while in multipoint analysis false exclusion of linkage
may occur [36]. In addition, genotyping errors may cause
false exclusion in multipoint analysis [37] and incorrect
allele frequencies and recombination fractions may result
in reduced power and/or false positive findings [38]. In
the present study we performed both two-point and
multipoint analysis, the former being the most robust
type of analysis and the latter using the most information.
Both when narrow and broad PD were analyzed there
were only small differences between two-point parametric
lod scores at theta = 0 and multipoint parametric lod
scores. At theta = 0.1, differences between two-point and
multipoint lod scores were larger, although the scores
were still negative for all markers except three. Neverthe-
less, this fact may indicate possible presence of bias in the
parametric multipoint analysis due to errors in specifica-
tion of the model parameters.
One problem related to the specification of inheritance
model is low penetrance. Given the complex phenotype,
including only affected individuals in the analysis may be
preferable. To compare this approach with the results
from the autosomal dominant model with reduced pene-
trance including all individuals, we performed affecteds-
only analysis for the PARK3 locus, which also initially was
identified using this approach [9]. Compared to the auto-
somal dominant model with incomplete penetrance,
multipoint parametric lod scores generated by the affect-
eds-only model were higher (less negative), indicating a
loss of information. Accordingly, information content as
given by Genehunter was markedly reduced. Thus, despite
the fact that affecteds-only analysis had been preferable,
the loss of information content precluded further affect-
eds-only analyses for the other loci. Since inheritance
mode in the families appeared autosomal dominant, it
seemed appropriate to perform the analyses under such a
model. Using data from a select number of markers we
evaluated age-dependent penetrance versus low pene-
trance for all age groups. The latter model generated some-
what higher (less negative) lod scores, indicating more
conservative values, however there were no large differ-
ences. Since low penetrance for all age groups imposes
fewer restrictions to the model, we subsequently chose to
model penetrance in this way.
The parametric linkage analysis was complemented with
a non-parametric linkage approach, which has the advan-BMC Neurology 2003, 3 http://www.biomedcentral.com/1471-2377/3/6
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tage of not making assumptions about inheritance mode
although it is less powerful than parametric linkage anal-
ysis. This fact is reflected by the data in the sense that the
non-parametric multipoint lod scores often approached
zero. Generally, the non-parametric analysis generated
higher lod scores than the parametric, a fact that was most
apparent when comparing multipoint non-parametric lod
scores to two-point lod scores at theta = 0 and multipoint
parametric lod scores, respectively. When comparing
multipoint non-parametric lod scores to two-point lod
scores at theta = 0.1, differences were smaller. The reason
for the discrepancy is most likely that in parametric anal-
ysis assumptions are made about mode of inheritance,
imposing restrictions to the data structure. Again,
multipoint parametric analysis is more sensitive to mode-
ling errors than two-point analysis, with the possible
effect of inducing false exclusions [35,36]. In summary,
although the multipoint parametric results indicated
exclusion of linkage, our sample contained too few
affected individuals in order to draw definite conclusions
from the non-parametric analysis. Thus, we are less
inclined to say that linkage is excluded based on the non-
parametric results.
One fact that might reduce our possibility to demonstrate
linkage is heterogeneity. At present there is substantial evi-
dence that several genes contribute to PD. Unfortunately,
we were unable to investigate heterogeneity in this study
due to the small sample size. However, some families
demonstrated positive lod scores for a few loci, indicating
that heterogeneity might exist despite our selection of
Caucasian families of European descent from a limited
geographical area.
Conclusions
The etiology of PD is considered to be complex, involving
several genetic factors as well as potential interactions
between genetic and environmental factors [1]. We con-
clude that using both parametric and non-parametric
linkage analyses there was no evidence for linkage to PD
in the families included in this study. Although linkage
was excluded for the majority of loci under an autosomal
dominant model with incomplete penetrance, we could
not exclude linkage using non-parametric methods. The
fact that none of the loci tested showed negative lod scores
in all families demonstrates the possibility that some of
them are of relevance to individual families. Alternatively,
other loci, known or yet unknown, may be associated
with PD in these families.
Competing interests
None declared.
Authors' contributions
KW participated in the design of the study and the geno-
typing, performed the linkage analyses and drafted the
manuscript. CEB participated in the design of the study
and the linkage analyses. LW participated in the genotyp-
ing. HP was responsible for the collection of blood sam-
ples. MS conceived of the study and participated in its
design and coordination. All authors read and approved
the manuscript.
Additional material
Acknowledgements
The authors thank Dr John Nutt, Department of Neurology, Oregon 
Health Sciences University, Portland, Oregon for ascertainment of the 
patients. This work was supported by the Swedish Research Council 
(10909), Kapten Eriksson foundation, funds from Karolinska Hospital and 
Karolinska Institutet, NARSAD and National Institutes of Health grant 1 
RO1 NS36960.
References
1. Payami H and Zareparsi S: Genetic epidemiology of Parkinson's
disease. J Geriatr Psychiatry Neurol 1998, 11:98-106.
2. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pick-
ering-Brown S, Chakraverty S, Isaacs A and Grover A et al.: Associ-
ation of missense and 5'-splice-site mutations in tau with the
inherited dementia FTDP-17. Nature 1998, 393:702-705.
3. Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, Nomura
Y, Endo K, Tanaka H and Tsuji S et al.: Hereditary progressive dys-
tonia with marked diurnal fluctuation caused by mutations
in the GTP cyclohydrolase I gene. Nat Genet 1994, 8:236-242.
4. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A,
Pike B, Root H, Rubenstein J and Boyer R et al.: Mutation in the
alpha-synuclein gene identified in families with Parkinson's
disease. Science 1997, 276:2045-2047.
Additional File 1
Table 3. Two-point and multipoint parametric lod scores (lod) and non-
parametric multipoint lod scores (NPL) for each marker. Summarized lod 
and NPL are shown for narrow and broad definition PD. Two-point lod 
scores were generated by Fastlink [32] and multipoint lod scores by Gene-
hunter [33]. In narrow definition PD only individuals with probable PD 
were assigned as affected, while in broad definition PD, individuals with 
possible PD were assigned as affected in addition to individuals with prob-
able PD. Since only one marker was used for the Ret locus, multipoint par-
ametric lod score is not shown.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2377-3-6-S1.xls]
Additional File 2
Table 4. Parametric (lod) and non-parametric (NPL) multipoint lod 
scores in individual families. Lod and NPL for narrow and broad defini-
tion PD for each family and locus in which both lod and NPL were positive 
and either of them exceeded the value of 0.5 for all markers. For the Ret 
locus, two-point parametric lod score is shown instead of lod since only one 
marker was used. The GDNF locus is omitted from the table since lod and 
NPL for this locus did not reach the required values in any families.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2377-3-6-S2.xls]BMC Neurology 2003, 3 http://www.biomedcentral.com/1471-2377/3/6
Page 7 of 7
(page number not for citation purposes)
5. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y,
Minoshima S, Yokochi M, Mizuno Y and Shimizu N: Mutations in the
parkin gene cause autosomal recessive juvenile
parkinsonism. Nature 1998, 392:605-608.
6. Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T,
Harhangi BS, Meco G, Denefle P and Wood NW et al.: Association
between early-onset Parkinson's disease and mutations in
the parkin gene. French Parkinson's Disease Genetics Study
Group. N Engl J Med 2000, 342:1560-1567.
7. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G,
Brownstein MJ, Jonnalagada S and Chernova T et al.: The ubiquitin
pathway in Parkinson's disease. Nature 1998, 395:451-452.
8. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E,
Dekker MC, Squitieri F, Ibanez P and Joosse M et al.: Mutations in
the DJ-1 gene associated with autosomal recessive early-
onset parkinsonism. Science 2003, 299:256-259.
9. Gasser T, Muller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB,
Bonifati V, Bereznai B, Fabrizio E, Vieregge P and Horstmann RD: A
susceptibility locus for Parkinson's disease maps to chromo-
some 2p13. Nat Genet 1998, 18:262-265.
10. Farrer M, Gwinn-Hardy K, Muenter M, DeVrieze FW, Crook R,
Perez-Tur J, Lincoln S, Maraganore D, Adler C and Newman S et al.:
A chromosome 4p haplotype segregating with Parkinson's
disease and postural tremor. Hum Mol Genet 1999, 8:81-85.
11. Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali
M, Albanese A and Wood NW: Localization of a novel locus for
autosomal recessive early-onset parkinsonism, PARK6, on
human chromosome 1p35-p36.  Am J Hum Genet 2001,
68:895-900.
12. Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS,
Sainz J, Frigge ML, Kong A, Gulcher JR and Stefansson K et al.: A sus-
ceptibility gene for late-onset idiopathic Parkinson's disease.
Ann Neurol 2002, 52:549-555.
13. Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S and Obata F: A
new locus for Parkinson's disease (PARK8) maps to chromo-
some 12p11.2-q13.1. Ann Neurol 2002, 51:296-301.
14. Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C,
Conneally PM and Foroud T: Significant linkage of Parkinson dis-
ease to chromosome 2q36-37.  Am J Hum Genet 2003,
72:1053-1057.
15. Zareparsi S, Kaye J, Camicioli R, Kramer P, Nutt J, Bird T, Litt M,
Payami H and Kay J: Analysis of the alpha-synuclein G209A
mutation in familial Parkinson's disease.  Lancet 1998,
351:37-38.
16. Zareparsi S, Wirdefeldt K, Burgess CE, Nutt J, Kramer P, Schalling M
and Payami H: Exclusion of dominant mutations within the
FTDP-17 locus on chromosome 17 for Parkinson's disease.
Neurosci Lett 1999, 272:140-142.
17. Murer MG, Yan Q and Raisman-Vozari R: Brain-derived neuro-
trophic factor in the control human brain, and in Alzhe-
imer's disease and Parkinson's disease.  Prog Neurobiol 2001,
63:71-124.
18. Saarma M and Sariola H: Other neurotrophic factors: glial cell
line-derived neurotrophic factor (GDNF).  Microsc Res Tech
1999, 45:292-302.
19. Frim DM, Uhler TA, Galpern WR, Beal MF, Breakefield XO and Isac-
son O: Implanted fibroblasts genetically engineered to pro-
duce brain-derived neurotrophic factor prevent 1-methyl-4-
phenylpyridinium toxicity to dopaminergic neurons in the
rat. Proc Natl Acad Sci U S A 1994, 91:5104-5108.
20. Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri
H, Davidson BL and Bohn MC: Dopaminergic neurons protected
from degeneration by G D N F  g e n e  t h e r a p y .   Science 1997,
275:838-841.
21. Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck
CD, Gray C, Armanini MP, Pollock RA and Hefti F et al.: Character-
ization of a multicomponent receptor for GDNF. Nature 1996,
382:80-83.
22. Amara SG and Kuhar MJ: Neurotransmitter transporters:
recent progress. Annu Rev Neurosci 1993, 16:73-93.
23. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L and Perl-
mann T: Dopamine neuron agenesis in Nurr1-deficient mice.
Science 1997, 276:248-250.
24. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG and Vassilatis
DK: Mutations in NR4A2 associated with familial Parkinson
disease. Nat Genet 2003, 33:85-89.
25. Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein
JJ, Margolis RL, Troncoso JC, Lanahan AA and Worley PF et al.: Syn-
philin-1 associates with alpha-synuclein and promotes the
formation of cytosolic inclusions. Nat Genet 1999, 22:110-114.
26. Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA and
Takahashi H: Synphilin-1 is present in Lewy bodies in Parkin-
son's disease. Ann Neurol 2000, 47:521-523.
27. Hughes AJ, Daniel SE, Kilford L and Lees AJ: Accuracy of clinical
diagnosis of idiopathic Parkinson's disease: a clinico-patho-
logical study of 100 cases.  J Neurol Neurosurg Psychiatry 1992,
55:181-184.
28. Boehnke M: Estimating the power of a proposed linkage study:
a practical computer simulation approach. Am J Hum Genet
1986, 39:513-527.
29. National Center for Biotechnology Information  [http://
www.ncbi.nlm.nih.gov]
30. Gulcher JR, Jonsson P, Kong A, Kristjansson K, Frigge ML, Karason A,
Einarsdottir IE, Stefansson H, Einarsdottir AS and Sigurthoardottir S
et al.: Mapping of a familial essential tremor gene, FET1, to
chromosome 3q13. Nat Genet 1997, 17:84-87.
31. Love DR, Gardner E and Ponder BA: A polymorphic dinucleotide
repeat at the D10S141 locus. Hum Mol Genet 1993, 2:491.
32. Cottingham RW Jr, Idury RM and Schaffer AA: Faster sequential
genetic linkage computations. Am J Hum Genet 1993, 53:252-263.
33. Kruglyak L, Daly MJ, Reeve-Daly MP and Lander ES: Parametric and
nonparametric linkage analysis: a unified multipoint
approach. Am J Hum Genet 1996, 58:1347-1363.
34. Sobel E and Lange K: Descent graphs in pedigree analysis: appli-
cations to haplotyping, location scores, and marker-sharing
statistics. Am J Hum Genet 1996, 58:1323-1337.
35. Risch N and Giuffra L: Model misspecification and multipoint
linkage analysis. Hum Hered 1992, 42:77-92.
36. Goring HH and Terwilliger JD: Linkage analysis in the presence
of errors I: complex-valued recombination fractions and
complex phenotypes. Am J Hum Genet 2000, 66:1095-1106.
37. Goring HH and Terwilliger JD: Linkage analysis in the presence
of errors II: marker-locus genotyping errors modeled with
hypercomplex recombination fractions. Am J Hum Genet 2000,
66:1107-1118.
38. Goring HH and Terwilliger JD: Linkage analysis in the presence
of errors III: marker loci and their map as nuisance
parameters. Am J Hum Genet 2000, 66:1298-1309.
39. Mages HW, Rilke O, Bravo R, Senger G and Kroczek RA: NOT, a
human immediate-early response gene closely related to the
steroid/thyroid hormone receptor NAK1/TR3. Mol Endocrinol
1994, 8:1583-1591.
40. Vandenbergh DJ, Persico AM and Uhl GR: A human dopamine
transporter cDNA predicts reduced glycosylation, displays a
novel repetitive element and provides racially-dimorphic
TaqI RFLPs. Brain Res Mol Brain Res 1992, 15:161-166.
41. Schindelhauer D, Schuffenhauer S, Gasser T, Steinkasserer A and
Meitinger T: The gene coding for glial cell line derived neuro-
trophic factor (GDNF) maps to chromosome 5p12-p13.1.
Genomics 1995, 28:605-607.
42. Ishizaka Y, Itoh F, Tahira T, Ikeda I, Sugimura T, Tucker J, Fertitta A,
Carrano AV and Nagao M: Human ret proto-oncogene mapped
to chromosome 10q11.2. Oncogene 1989, 4:1519-1521.
43. Maisonpierre PC, Le Beau MM, Espinosa R 3rd, Ip NY, Belluscio L, de
la Monte SM, Squinto S, Furth ME and Yancopoulos GD: Human and
rat brain-derived neurotrophic factor and neurotrophin-3:
gene structures, distributions, and chromosomal
localizations. Genomics 1991, 10:558-568.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2377/3/6/prepub